Acta Med. 2016, 59: 22-25

https://doi.org/10.14712/18059694.2016.51

Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still’s Disease

Xavier Vandemergela, Frédéric Vandergheynstb

aDepartment of General Internal Medicine, Centres Hospitaliers Jolimont, Nivelles, Belgium
bCUB Hôpital Erasme, Nivelles, Belgium

Received October 13, 2015
Accepted November 23, 2015

Crossref Cited-by Linking

  • Giacomelli Roberto, Caporali Roberto, Ciccia Francesco, Colafrancesco Serena, Dagna Lorenzo, Govoni Marcello, Iannone Florenzo, Leccese Pietro, Montecucco Carlomaurizio, Pappagallo Giovanni, Pistone Giovanni, Priori Roberta, Ruscitti Piero, Sfriso Paolo, Cantarini Luca, Belfiore Norma, Bernardi Cristina, Gabini Marco, Bettio Silvano, Brucato Antonio, Italiano Giovanni, Cantatore Francesco Paolo, Iacono Daniela, Pantano Ilenia, Tirri Enrico, Ursini Francesco, Monaco Andrea Lo, Caso Francesco, Quartuccio Luca, Chimenti Maria Sole, Gattamelata Angelica, Gremese Elisa, Paroli Marino, Picchianti-Diamanti Andrea, Sebastiani Gian Domenico, Favalli Ennio, Sulli Alberto, Frassi Micol, Faggioli Paola, Foti Rosario, Campochiaro Corrado, Cavalli Giulio, Tomelleri Alessandro, Manara Maria, De Stefano Ludovico, De Angelis Rossella, Parisi Simone, Lopalco Giuseppe, Piga Matteo, Marotto Daniela, Colaci Michele, Padula Angela, Guggino Giuliana, Emmi Giacomo, Baldini Chiara, Sota Jurgen, Vitale Antonio, Berti Alvise, Bartoloni Elena, Grava Chiara, Bindoli Sara, Vitetta Rosetta: Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission. Autoimmunity Reviews 2023, 22, 103400. <https://doi.org/10.1016/j.autrev.2023.103400>
  • Torigoe Masataka, Maeshima Keisuke, Kuriyama Yuhei, Abe Itomi, Ozaki Takashi, Omura Yuichi, Umeki Tatsuhito, Imada Chiharu, Ishii Koji, Shibata Hirotaka: Effectiveness of subcutaneous tocilizumab in refractory adult Still’s disease: report of three cases and a review of the literature. Modern Rheumatology Case Reports 2021, 5, 365. <https://doi.org/10.1080/24725625.2021.1886402>
  • Reihl Crnogaj Mirna, Čubelić Darija, Babić Antonija, Mayer Miroslav, Anić Branimir: Treatment of refractory adult onset Still’s disease with tocilizumab—a single centre experience and literature review. Rheumatol Int 2020, 40, 1317. <https://doi.org/10.1007/s00296-020-04622-4>
  • Simeni Njonnou Sylvain Raoul, Soyfoo Muhammad Shahnawaz, Vandergheynst Frédéric-Alain: Efficacy of sarilumab in adult-onset Still’s disease as a corticosteroid-sparing agent. Rheumatology 2019, 58, 1878. <https://doi.org/10.1093/rheumatology/kez154>
  • Lima J.P., Andrade J.P.S., Garcia J.M.C.A., Villela A.L.M., Campos G.S.: DOENÇA DE STILL DO ADULTO GRAVE COM REMISSÃO APÓS TOCILIZUMABE: RELATO DE CASO. Revista Brasileira de Reumatologia 2017, 57, S290. <https://doi.org/10.1016/j.rbr.2017.07.380>
  • Adam Zdeněk, Skřičková Jana, Krtička Milan, Řehák Zdeněk, Koukalová Renata, Šprláková Andrea, Krejčí Marta, Pour Luděk, Adamová Zdenka, Pourová Eva, Král Zdeněk: Remission of steroid-resistant Still's disease treated with anakinra, evidenced by FDG-PET/CT examination: case report. Vnitř Lék 2017, 63, 987. <https://doi.org/10.36290/vnl.2017.179>
Crossref Cited-by Linking logo